Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

Two office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for Globus Medical. The company ...

Welcome to Globus Medical's second-quarter 2021 earnings call. [Operator instructions]. I will now turn the call over to Kelly Huller, senior vice president, general counsel. Ms. Huller ...

Globus Medical stands out for its commitment to improving patient care through advanced technology, including regenerative biologic products. Founded in 2003 and based in Audubon, Pennsylvania ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...